Skip to main content

Table 1 Food and Drug Administration (FDA)-approved small molecule HIV therapeutics

From: A plant-biotechnology approach for producing highly potent anti-HIV antibodies for antiretroviral therapy consideration

Drug type

Drug name

Nucleoside/nucleotide reverse transcriptase inhibitors

Abacavir, emtricitabine, lamivudine; tenofovir disoproxil fumarate, zidovudine

NNRTIs non-nucleoside reverse transcriptase inhibitors

Efavirenz, etravirine, nevirapine, rilpivirine

Fusion inhibitors

Enfuvirtide

Protease inhibitors

Atazanavir, darunavir, fosamprenavir, ritonavir, saquinavir, tipranavir

C-C chemokine receptor type 5 (CCR5)

Maraviroc

Integrase inhibitors

Dolutegavir, raltegravir, elvitegravir, bictegravir